Caution on COX inhibitor use in preterm infants
Very-low-birthweight preterm infants with thrombocytopenia treated with cyclooxygenase inhibitors are at an increased risk for intracerebral hemorrhage, particularly if they have decreased platelet levels, research shows.
Source: MedWire News - Pediatrics - Category: Pediatrics Source Type: news
More News: Pediatrics | Thrombocytopenia